Trixin 250 mg kapsule
| Name | Trixin 250 mg kapsule |
|---|---|
| Former Name | Myfenax 250 mg tvrde kapsule |
| Marketing Authorisation Number | HR-H-113442228 |
| Active Substance | mofetilmikofenolat |
| Composition | jedna kapsula sadrži 250 mg mofetilmikofenolata |
| Pharmaceutical Form | kapsula, tvrda |
| Packaging [MA Number for Packaging] | 100 kapsula u blisteru, u kutiji [HR-H-113442228-01] |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Pharmaceutical Works Private Limited Company, Debrecen, Mađarska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.07.2014 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/13-02/466 |
| Registration Number | 381-12-01/70-14-08 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L04AA06 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Educational materials for healthcare professionals |
Vodič za zdravstvene radnike, verzija 2 |
| Educational materials for patients / caregivers |
Vodič za bolesnike, verzija 2 |
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o izmijenjenim preporukama za kontracepciju povezanim s primjenom mofetilmikofenolata/mikofenolatne kiseline (CellCept, Myfortic, Trixin) | 22.01.2018 | Roche d.o.o., Novartis Hrvatska d.o.o., Pliva Hrvatska d.o.o. |
